A detailed history of Aquatic Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aquatic Capital Management LLC holds 24,800 shares of NBIX stock, worth $3.11 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
24,800
Holding current value
$3.11 Million
% of portfolio
0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $3.25 Million - $3.55 Million
24,800 New
24,800 $3.41 Million
Q1 2023

May 15, 2023

BUY
$94.11 - $123.02 $56,466 - $73,812
600 New
600 $61,000
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $2.25 Million - $2.64 Million
24,500 Added 942.31%
27,100 $2.88 Million
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $197,054 - $260,181
2,600 New
2,600 $253,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.